CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −655 | $75.49 | $49K | 0 |
| 2023-06-14 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,669 | 205,331 | ||
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Option exercise 10b5-1 | +15,000 | $29.81 | $447K | 15,000 |
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $12.15 | $49K | 19,000 |
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −2,943 | $70.02 | $206K | 16,057 |
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −12,004 | $70.99 | $852K | 4,053 |
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −3,759 | $71.96 | $270K | 294 |
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −294 | $73.14 | $22K | 0 |
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 0 | ||
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 66,000 | ||
| 2023-06-07 | Karp Carol D. Chief Regulatory Officer | Option exercise 10b5-1 | +5,000 | $12.15 | $61K | 5,000 |
| 2023-06-07 | Karp Carol D. Chief Regulatory Officer | Option exercise 10b5-1 | +15,000 | $13.53 | $203K | 20,000 |
| 2023-06-07 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −3,046 | $69.90 | $213K | 16,954 |
| 2023-06-07 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −12,782 | $71.00 | $907K | 4,172 |
| 2023-06-07 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −3,811 | $71.97 | $274K | 361 |
| 2023-06-07 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −361 | $72.93 | $26K | 0 |
| 2023-06-07 | Karp Carol D. Chief Regulatory Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 65,000 | ||
| 2023-06-07 | Karp Carol D. Chief Regulatory Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 35,000 | ||
| 2023-05-31 | Malecek Michael J Chief Legal Officer | Option exercise 10b5-1 | +5,000 | $10.27 | $51K | 5,000 |
| 2023-05-31 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −3,211 | $64.16 | $206K | 1,789 |
Page 13 of 28 · 555 trades